(Q38131030)

29 August 2017

Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

29 August 2017

0 references

1 reference

Mohamed M Radwan

1

1 reference

29 August 2017

Basil M Radwan

2

1 reference

29 August 2017

Kalyana C Nandipati

3

1 reference

29 August 2017

William J Hunter

4

1 reference

29 August 2017

Devendra K Agrawal

5

1 reference

29 August 2017

1 August 2013

1 reference

Expert Review of Clinical Immunology

29 August 2017

1 reference

29 August 2017

9

1 reference

29 August 2017

8

1 reference

29 August 2017

727-738

1 reference

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

29 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Ethnicity and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

NAFLD in Asia--as common and important as in the West

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Population-based risk factors and resource utilization for HCC: US perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Fatty liver: a novel component of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Causes and metabolic consequences of Fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

The burden of overweight and obesity-related ill health in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Global prevalence and trends of overweight and obesity among preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Epidemiology of non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

The metabolically benign and malignant fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

A stress signaling pathway in adipose tissue regulates hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Sex hormone binding globulin and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Fructose: it's "alcohol without the buzz".

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Free fatty acid-induced hepatic insulin resistance is attenuated following lifestyle intervention in obese individuals with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Macrophage-mediated inflammation in metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Adipose tissue remodeling and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Adipose tissue-resident immune cells: key players in immunometabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Design principles of adaptive immune systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Lipid-induced insulin resistance: unravelling the mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Macrophages, inflammation, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

IKK-beta links inflammation to obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Prevention of fat-induced insulin resistance by salicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Insulin protects liver cells from saturated fatty acid-induced apoptosis via inhibition of c-Jun NH2 terminal kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

JNK1 but not JNK2 promotes the development of steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Lack of Fas antagonism by Met in human fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Animal models of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Toll-like receptors and adaptor molecules in liver disease: update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Heritability of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Phosphatidylethanolamine N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

The emergence of the metabolic syndrome with menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Endocrine and liver interaction: the role of endocrine pathways in NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

A human-type nonalcoholic steatohepatitis model with advanced fibrosis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

Dissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.816484

10.1586/1744666X.2013.816484

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference